Bicocca Open Archive

Logo unimib boa
REDAELLI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.167
EU - Europa 2.599
AS - Asia 885
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 7
AF - Africa 3
OC - Oceania 2
Totale 8.672
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.084
DE - Germania 609
IT - Italia 494
CN - Cina 388
IE - Irlanda 374
SE - Svezia 370
SG - Singapore 276
UA - Ucraina 222
RU - Federazione Russa 168
GB - Regno Unito 133
CA - Canada 83
HK - Hong Kong 75
FI - Finlandia 58
IN - India 46
FR - Francia 45
VN - Vietnam 43
BE - Belgio 34
TR - Turchia 27
DK - Danimarca 26
PL - Polonia 16
AT - Austria 14
NL - Olanda 14
EU - Europa 9
IR - Iran 9
KR - Corea 7
ID - Indonesia 6
BG - Bulgaria 5
CZ - Repubblica Ceca 5
BR - Brasile 4
ES - Italia 4
CL - Cile 2
EG - Egitto 2
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
JP - Giappone 1
LU - Lussemburgo 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 8.672
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.126
Woodbridge 589
Fairfield 455
Chandler 372
Dublin 362
Frankfurt am Main 344
Houston 298
Ashburn 271
Wilmington 257
Dearborn 235
Jacksonville 225
Milan 221
Singapore 195
Seattle 183
Cambridge 137
New York 129
Princeton 101
Göttingen 75
Hong Kong 74
Nanjing 72
Shanghai 71
Altamura 49
Lawrence 42
Lachine 37
Santa Clara 37
Beijing 34
Brussels 34
Boardman 26
Dong Ket 26
Nanchang 26
Fremont 25
Fürstenwalde 25
San Diego 23
Shenyang 23
Guangzhou 19
Helsinki 19
Andover 18
Ottawa 18
Tianjin 17
Falls Church 16
Jiaxing 15
Lodz 15
Hangzhou 14
Jinan 14
Toronto 14
Kocaeli 13
Lissone 13
Los Angeles 13
Munich 13
Vienna 13
Changsha 12
Hebei 12
Hefei 11
London 11
Monza 11
Norwalk 11
Pavia 11
Huizen 10
Pune 10
Edmonton 9
Kunming 9
Nürnberg 8
Rome 8
Bonndorf 7
Kiev 7
Moscow 7
Ningbo 7
Cinisello Balsamo 6
Jakarta 6
Kilburn 6
Mountain View 6
Zhengzhou 6
Desio 5
Meda 5
Mumbai 5
Zanjan 5
Carate Brianza 4
Chicago 4
Daejeon 4
Hounslow 4
Philadelphia 4
Plovdiv 4
Redmond 4
San Mateo 4
Auburn Hills 3
Birmingham 3
Ceret 3
Cesena 3
Clifton 3
Dallas 3
Dottingen 3
Fuzhou 3
Haikou 3
Olomouc 3
San Francisco 3
Serio 3
St Petersburg 3
Taizhou 3
Washington 3
Agrate Brianza 2
Totale 6.733
Salva come PNG Salva come JPEG
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 392
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 350
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 302
Characterization of compound 584, an Abl kinase inhibitor with lasting effects 259
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 249
Three novel patients derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors 235
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells 226
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma 213
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 211
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib 203
Structural insights into the ATP binding pocket of the anaplastic lymphoma kinase by site-directed mutagenesis, inhibitor binding analysis, and homology modeling 198
NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma 197
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 197
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients 195
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 195
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 193
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 188
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase 186
Abstract 902: In vitro andin vivocharacterization of resistance to lorlatinib treatment in ALK mutated cancers 185
Inhibition of RET tyrosine kinase by SU5416 183
A New BCR-ABL1 Mutation (L248R) Is Highly Resistant to Imatinib, Bosutinib, Nilotinib and Dasatinib, but Can Be Inhibited by AP-24534 and DCC-2036 181
Reply to P. Laneuville et al 179
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 178
Expression, purification, and inhibition of human RET tyrosine kinase 174
Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants 174
ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells 174
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 165
Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation 162
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 161
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 156
Dual kinase targeting in leukemia 155
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 153
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 147
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 146
NPM/ALK binds and phosphorylates the RNA/DNA binding protein PSF in anaplastic large cell lymphoma 145
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib 142
In Vitro and in Vivo Characterization of Bosutinib as Substrate of the Pglycoprotein Efflux Transporter 141
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 136
Novel targeted therapeutics for MEN2 136
Determination of the Activity Profile of Bosutinib, Dasatinib and Nilotinib against 18 Imatinib Resistant Bcr/Abl Mutants 130
BCR and BCR/ABL Regulation during Myeloid Differentiation in Healthy Donors and in Chronic Phase/Blast Crisis CML Patients 128
In vitro and in vivo activity of SKI-606, a novel Abl/Src inhibitor, against imatinib resistant BCR-ABL plus neoplastic 126
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 122
Bosutinib is a Substrate of the ABC Efflux Transporter P-Glycoprotein 117
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBa mediated p53 nuclear exclusion 114
Volatile Sedation for Acute Respiratory Distress Syndrome Patients on Venovenous Extracorporeal Membrane Oxygenation and Ultraprotective Ventilation 114
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 110
Resistance Profile of the BCR/ABL Inhibitor Bosutinib Using a High Throughput random Mutagenesis Assay 106
Rapid recognition of drug-resistance/sensitivity in leukemic cells by Fourier transform InfraRed microspectroscopy and unsupervised Hierarchical Cluster Analysis. 105
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma 101
Idiopathic erythrocytosis: a germline disease? 69
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 51
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis 48
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 34
Totale 9.037
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.102
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.454 0 0 122 139 170 215 282 119 159 111 96 41
2020/20211.352 58 73 116 134 118 152 107 126 126 137 103 102
2021/2022755 53 77 83 47 51 70 38 34 37 81 64 120
2022/20231.491 169 461 145 151 93 197 18 81 84 23 33 36
2023/20241.066 28 34 43 60 139 299 217 38 54 23 15 116
2024/2025479 141 224 114 0 0 0 0 0 0 0 0 0
Totale 9.037